Regeneron Pharmaceuticals’ (REGN) CEO Leonard Schleifer on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Leonard S. Schleifer Thanks, Michael, and good morning, everyone. The first quarter was another significant quarter for Regeneron. The global EYLEA franchise continued to grow, and I will address that … more

View todays social media effects on REGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Regeneron is hiring next, click here to view